Navigation Links
Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results
Date:3/16/2009

rtible debt 142,373 137,396 Accumulated deficit (1,312,320) (1,109,413) Shareholders' deficit (132,061) (134,125) (1) Amounts reflect a one-for-ten reverse stock split of our common stock effective August 31, 2008.


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
2. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 16
3. Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
4. Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients
5. Cell Therapeutics, Inc. (CTI) to Present at 11th Annual BIO CEO & Investor Conference
6. Cell Therapeutics, Inc. Provides Update on the Special Meeting of Shareholders
7. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes
8. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
9. Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides
10. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
11. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--...mpanyfocusedondevelopingandcommercializingnovelpai...nno,PresidentandChiefExecutiveOfficer,isscheduledt...rence,tobeheldDecember1-2,2009atTheNewYorkPalaceHo...iglieri,ChiefFinancialOfficer,willbeavailabletores...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswir...yCalottoCapitalInc.,aleadingproviderofadvancedlase...tilityclinicmarkets,todayreportedoperationalandfin...09. , ,Q32009Highlights,-Revenuewas$1.46millionc...was66.3percentcomparedwith66.1percentinQ3,2008,-Ne...
(Date:11/24/2009)... Program Connects Customers w...les Collected with DNA Genotek Products , ...009 -- DNA Genotek , a leading provider of produc... and preparation, today announced its new global p...ancements for DNA Genotek,s partner community and ...
(Date:11/23/2009)...antum computing promises ultra-fast communication,...sitive information. But trying to use quantum stat...cate business. Now two physicists have shown, math... in quantum communication, while keeping the infor...nt issue of Physical Review Letters and highligh...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...LOS ANGELES, Aug. 31 Signalife, Inc. (Amex:,SGN),...ecutive, has release,the following corporate updat... month: 1. Dr. Harmison has already "cleaned hous...ere producing no revenue whatsoever and no hope of...view. That was done immediately by Dr. Harmis...
...herapeutics, Inc.,announced today that it has file...curities and Exchange Commission for a proposed in...k. All of the shares in the proposed,offering will...f the offering will be Morgan Stanley & Co.,Incorp... and CIBC World,Markets Corp., Jefferies & Company...
...Allergy Testing in Managing Chronic ...0 Phadia US Inc. announced today,that The Nationa...has,issued an update on selected topics in the Gui.... Information in the guidelines reported that alle...ctors in the development,persistence and potential...
Other Biology Technology:Signalife Provides Corporate Update 2Signalife Provides Corporate Update 3ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering 2Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management 2
(Date:11/24/2009)...ay named 12 new grant recipients for 2009. The awa...ork across a broad spectrum of lupus research. All...potential to drive scientific discovery to ultimat...f systemic lupus. , The 2009 grants go to both n...tion and include interdisciplinary and highly prom...
(Date:11/24/2009)...e class of ring-shaped protein motors has been unc...ational Laboratory (Berkeley Lab) using a state-of...dvanced Light Source (ALS). These protein motors p...on, and are vital to the survival of all biologica... human papillomavirus, which has been linked to ce...
(Date:11/24/2009)...r of debate. A high-profile study a few years ago ... carbon from trees and leaves, evidence for a very...osystems. , But new research from the University.... Algae provide a much richer diet for fish and ot...this week in the Proceedings of the National Acad...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Lexicon Announces Proposed Offering of 27 500 000 Shares of Common Stock 14390 1Lexicon Announces Proposed Offering of 27 500 000 Shares of Common Stock 14390 2Lexicon Announces Proposed Offering of 27 500 000 Shares of Common Stock 14390 3Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary Sanvita Inc 5309 1Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary Sanvita Inc 5309 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A Weinberg Ph D to Its Scientific Advisory Board 5305 1Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A Weinberg Ph D to Its Scientific Advisory Board 5305 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A Weinberg Ph D to Its Scientific Advisory Board 5305 3
...th a photograph that embodies the unexpected and ...rsity of Wisconsin-Madison graduate student Jenna ...ngineering Visualization Challenge, sponsored by t...e. , The image, "Polymazing," appears in the Sept...omewhat amazing, considering the subject of her ph...
...HILADELPHIA - Biophysicists at the University of P...d long-established data on cholesterol,s role in t...interaction between cholesterol and neurotransmitt...ehavior for the nicotinic acetylcholine receptor, ...lzheimer,s disease, Parkinson,s disease, schizophr...
...SHINGTON Members of the public can send their nam...st mission dedicated to understanding the effects ...bility on our climate. , The "Send Your Name Arou...rt in the science mission and place their names in...icipants can submit their information, is located ...
Other Biology News:UW science photo takes second in national contest 2Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue 2Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue 3Send your name around the Earth on NASA'S Glory mission 2
...e/PAD: ZMD.283. Immunogen: Fusion protein derived... ASIP/PAR-3 (atypical PKC isotype-specific interac...gen is not related to the protease-activated-recep...us (positive controls: Caco-2 MDCK A6 cell lysates...
Rabbit Anti-Human MTHFD1 Polyclonal Antibody, Unconjugated from Atlas Antibodies
BioPrime Array CGH Genomic Labeling Module from Invitrogen
GIBCO F-12 Nutrient Mixture (Ham) powder from Invitrogen
Biology Products: